Danimer Scientific, Inc (DNMR) Q2 2024 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals several challenges: a significant revenue decline, negative EBITDA guidance, and supply chain issues impacting results. Despite optimistic future PHA revenue forecasts and cost-saving measures, competitive pressures, regulatory disruptions, and liquidity concerns pose risks. The Q&A session highlighted management's vague responses, adding uncertainty. The warrant program's potential benefits are overshadowed by a high debt burden. Overall, the negative financial performance and management's unclear guidance suggest a negative stock price movement in the short term.
Key Financial Performance
Total Revenue $7.6 million, down from $12.9 million (down 41% year-over-year) due to a decline in PHA revenues and PLA-based resin sales.
PHA Revenue $5.9 million, down $2.5 million (down 30% year-over-year) primarily due to Starbucks reallocating straw resin business.
PLA Revenue $1.4 million, down $2.4 million (decrease due to lost customer orders from the impact of the Ukraine conflict).
Gross Loss $6.9 million, consistent with the prior year quarter's gross loss of $6.6 million.
Adjusted Gross Loss $1.8 million, compared to an adjusted gross loss of $1.6 million in the prior year quarter.
R&D and SG&A Expenses $8.1 million, down from $8.6 million in the prior year due to cost control initiatives.
Adjusted EBITDA Loss $9.9 million, an improvement over a loss of $10.2 million in the second quarter of 2023.
Unrestricted Cash and Cash Equivalents $40.3 million, down from $59.2 million at the end of 2023.
Capital Expenditures $1.8 million, down from $6.6 million in the prior year due to diminished greenfield project equipment payments.
Total Debt Balance $394 million, primarily from convertible senior notes, senior secured term loan, and revolving asset-based credit agreement.
Annualized Cost Reductions $20 million since early 2022, including $7 million in annualized savings implemented at the end of Q2 2024.
Debt Retired through Warrant Program $6.1 million of outstanding 3.25% convertible notes permanently retired.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Product Launches: We are currently working with 6 of the top 8 QSRs in terms of annual volume of single-use plastic products, focusing on applications such as biodegradable straws and cutlery.
Commercial Trials: A large QSR is trialing our Nodax-based biodegradable straws in several states, with a larger commercial launch expected in late 2024 or early 2025.
New Applications: We continue to advance in the commercialization process of compostable cups using our PHA resins for both aqueous and extrusion coatings.
Market Expansion: We expect to achieve full capacity utilization of our Kentucky facility over the next several quarters, driven by existing customer demand and new awards.
Customer Engagement: We have conducted commercial trials and research-based sampling with hundreds of potential customers covering a vast array of products.
Operational Efficiencies: Implemented operational cost reductions resulting in approximately $7 million in annualized savings.
Cost Control Initiatives: Total annualized cost reductions since early 2022 now exceed $20 million.
Strategic Shifts: The CEO announced plans to retire and a search for a new leader to expand manufacturing capacity.
Debt Management: Launched a warrant dividend program to facilitate the conversion of convertible notes to equity, contributing to the deleveraging of the balance sheet.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Competitive Pressures: Some potential customers have been slow to deploy new technology due to rising costs and shifting priorities away from sustainability.
Regulatory Issues: The company faced disruptions due to COVID-19 shutdown orders, impacting key research and development projects.
Supply Chain Challenges: The reallocation of Starbucks' straw resin business to WinCup led to excess inventory and a negative impact on results, expected to carry over into the third quarter.
Economic Factors: PLA-based resin sales decreased due to lost customer orders from the impact of the Ukraine conflict.
Liquidity Management: The company is focused on managing liquidity, with a significant debt balance of $394 million and a need to maintain cash flow while ramping up sales.
Operational Costs: Operational cost reductions were implemented, resulting in approximately $7 million in annualized savings, including headcount reductions.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
PHA Production Scale-Up: Danimer is in the process of significant scale-up of its business, aiming for full capacity utilization of its Kentucky facility over the next several quarters.
Commercial Focus: The primary commercial focus is on the food service market, particularly quick service restaurants (QSRs), with ongoing partnerships with 6 of the top 8 QSRs.
Cost Reduction Initiatives: Operational cost reductions implemented at the end of Q2 2024 resulted in approximately $7 million in annualized savings.
Rinnovo Polymer Development: Continued progress on Rinnovo polymer R&D initiatives, which are expected to drive future revenue.
Warrant Dividend Program: The successful launch of a warrant dividend program aims to improve balance sheet leverage and reduce debt.
2024 Adjusted EBITDA Guidance: Expected adjusted EBITDA for 2024 is projected to be between -$39 million to -$35 million.
CapEx Guidance: Capital expenditures are expected to remain in the range of $8 million to $10 million for 2024.
Liquidity Guidance: End of year liquidity is estimated to be in the range of $15 million to $20 million.
PHA Revenue Forecast: Forecasting annualized PHA revenues to triple by the end of Q2 2025 based on existing customer demand.
Positive EBITDA Expectation: Expect to cross over to positive EBITDA in Q2 2025, with a run rate approaching $15 million of EBITDA annually by the end of 2025.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividend Warrant Program: The company successfully launched a warrant dividend program, where shareholders received one dividend warrant for each 3 shares of common stock held as of the record date. These warrants trade over-the-counter under the symbol DNMRW.
Warrant Features: The warrants can be exercised for common shares with cash or with the company's 3.25% convertible notes, allowing noteholders to exchange notes for common stock.
Debt Reduction: The program is expected to contribute to the deleveraging of the balance sheet and reduce cash interest expense. To date, the company has permanently retired $6.1 million of its outstanding 3.25% convertible notes.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are the sources of the reduced EBITDA guidance?
A:It's mostly the impact of the Starbucks inventory adjustment that's causing that.
Q:How much does halting the catalytic operations save annually? Can it be restarted easily?
A:We're saving about $1.5 million annually and retaining key employees to start back up when needed.
Q:Can you discuss the tolling and licensing arrangements beyond Kentucky?
A:We can't really talk about much detail there, but we're looking into it to bridge any potential gap in capacity.
Q:Is the tolling and licensing being demanded by customers?
A:It's indirectly being demanded by customers due to volume forecasts.
Q:Can you provide an update on the timing of the DOE?
A:Not specifically, but both teams are focused on getting it done before the end of the year.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer regarding the details of the tolling and licensing arrangements beyond Kentucky, stating they can't talk about much detail. Additionally, the response about the DOE timing was vague, lacking specific information.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Danimer Scientific
Hajost Chief
Nodax straw
PHA revenue
QSRs
Rinnovo
Starbucks straw
WinCup
application
asset
color
cost reduction
credit agreement
day
decision Danimer
dividend
end cost
epidemic
facility
licensing
liner
mission
noteholders
order
petroleum
phade straw
plastic product
polymer
product coffee
retirement
search
shutdown
straw resin
success
support
tolling
topic
use plastic
warrant
world
year
DNMR Transcript
Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript
Unknown11-20
The earnings call reveals declining revenue and significant financial risks, including a gross loss and high debt levels. Despite partnerships and cost-saving initiatives, the negative impact of Starbucks' reallocation and lack of liquidity guidance are concerning. The Q&A section did not provide clarity, furthering uncertainties. While there are positive developments like partnerships and cost savings, these are overshadowed by financial instability and operational risks. The absence of a clear liquidity outlook and unresolved leadership transition contribute to a negative sentiment.
Danimer Scientific, Inc (DNMR) Q2 2024 Earnings Call Transcript
Unknown8-10
The earnings call reveals several challenges: a significant revenue decline, negative EBITDA guidance, and supply chain issues impacting results. Despite optimistic future PHA revenue forecasts and cost-saving measures, competitive pressures, regulatory disruptions, and liquidity concerns pose risks. The Q&A session highlighted management's vague responses, adding uncertainty. The warrant program's potential benefits are overshadowed by a high debt burden. Overall, the negative financial performance and management's unclear guidance suggest a negative stock price movement in the short term.
Danimer Scientific, Inc. (DNMR) Q1 2024 Earnings Call Transcript
Unknown5-8
The earnings call indicates several challenges: significant revenue decline due to external conflicts, high debt levels, and liquidity concerns. While PHA revenues increased, overall sales dropped, and financial losses persist. The unresolved DOE loan adds uncertainty, and management's vague responses in the Q&A further dampen confidence. Despite some cost reductions and potential future operational improvements, the immediate outlook is negative, likely leading to a stock price decline.
Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript
Unknown3-28
The earnings call summary presents a mixed picture: positive developments such as potential DOE loan approval, strong demand, and cost reductions are offset by unclear guidance and the need for additional equity. The Q&A reveals optimism about future demand and partnerships but also highlights uncertainties in execution timing and financial commitments. Without specific guidance and given the lack of market cap data, the sentiment remains neutral.
DNMR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
